Revenue Update on STAAR Surgical Company(NASDAQ:STAA)

STAAR Surgical Company(NASDAQ:STAA) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Aug 3, 2016. Company reported revenue of $20.97M. Analysts estimated a revenue of $19.88M. Earnings per share were $-0.02. Analysts had estimated an EPS of $-0.05.

STAAR Surgical Company (STAA) made into the market gainers list on Fridays trading session with the shares advancing 7.63% or 0.63 points. Due to strong positive momentum, the stock ended at $8.89, which is also near the day’s high of $8.9. The stock began the session at $8.15 and the volume stood at 1,32,594 shares. The 52-week high of the shares is $9.21 and the 52 week low is $4.98. The company has a current market capitalization of $359 M and it has 4,04,31,411 shares in outstanding.

Several Insider Transactions has been reported to the SEC. On May 23, 2016, Richard A Meier (director) sold 25,000 shares at $5.34 per share price.Also, On Aug 26, 2015, Caren L Mason (CEO) purchased 10,000 shares at $7.34 per share price.On Aug 11, 2015, Lou Silverman (director) purchased 1,500 shares at $8.18 per share price, according to the Form-4 filing with the securities and exchange commission.

STAAR Surgical Company designs develops manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company’s principal products are intraocular lenses (IOLs) and implantable Collamer lenses (ICLs). IOLs are prosthetic intraocular lenses used to restore vision that has been adversely affected by cataracts and include the Company’s lines of silicone and Collamer IOLs and the Preloaded Injector (a silicone or acrylic IOL preloaded into a single-use disposable injector). ICLs consisting of the Company’s ICL and Toric implantable collamer lenses (TICL) are intraocular lenses used to correct refractive conditions such as myopia (near-sightedness) hyperopia (far-sightedness) and astigmatism. The Company operates under the brands STAAR Visian Collamer CentraFLOW AquaPORT nanoFLEX nanoPOINT Epiphany and AquaFlow. Collamer is the brand name for its collagen copolymer lens material.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

STAAR Surgical Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on STAAR Surgical Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.